Patents by Inventor Lior Yankelson

Lior Yankelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240043555
    Abstract: Provided herein is a method for treating or preventing a kidney disease or injury in a subject in need thereof, the method including administering to the subject a therapeutically effective amount of pharmaceutical composition including a CD24 inhibitor. Further provided is a method for inhibiting a damage associated molecular pattern (DAMP) in a subject, including administering to the subject a therapeutically effective amount of pharmaceutical composition including a CD24 inhibitor.
    Type: Application
    Filed: August 3, 2023
    Publication date: February 8, 2024
    Inventors: Idit F. SCHWARTZ, Nadir ARBER, Doron SCHWARTZ, Lior YANKELSON
  • Publication number: 20190046062
    Abstract: An electrode array configured to be inserted at least partially into a blood vessel including: a self-expandable array body; at least two axially spaced-apart electrodes connected to said array body; wherein at least part of said array body expands to an open conformation and pushes at least one selected electrode against a blood vessel inner tissue with a force designed not to damage venous tissue.
    Type: Application
    Filed: January 5, 2017
    Publication date: February 14, 2019
    Inventors: Lior YANKELSON, Omer SHEZIFI, Dima PINHASOV
  • Publication number: 20180272121
    Abstract: The present disclosure provides, according to some embodiments, methods and systems for treatment or prevention of ventricular symptoms of atrial fibrillation. For example, methods for applying sub-threshold electric fields to Av node and associated tissue, for example, from inside a coronary sinus.
    Type: Application
    Filed: January 7, 2016
    Publication date: September 27, 2018
    Inventor: Lior YANKELSON
  • Patent number: 8703119
    Abstract: Methods for soft tissue repair and/or augmentation using injectable, biodegradable polymers are described herein. In one embodiment, the polymer compositions are liquid or pastes at room temperature. In a preferred embodiment, the polymer composition contains liquid or pasty hydroxy fatty acid-based copolyesters, polyester-anhydrides, or combinations thereof. The viscosity of the polymers increases upon contact with bodily fluid to form a solid or semisolid implant suitable for soft tissue repair and/or augmentation. In another embodiment, the polymer composition contains particles of a polymer stereocomplex. One or more active agents may be incorporated into the polymer compositions. Suitable classes of active agents include local anesthetics, anti-inflammatory agents, antibiotics, analgesics, growth factors and agents that induce and/or enhance growth of tissue within the filled cavity or control the growth of a certain type of tissue, and combinations thereof.
    Type: Grant
    Filed: October 5, 2008
    Date of Patent: April 22, 2014
    Assignee: Polygene Ltd.
    Inventors: Lior Yankelson, Abraham J. Domb
  • Publication number: 20120294827
    Abstract: A polymer gel, in at least some embodiments, featuring both cross-linked castor oil and branched castor oil components, in which the castor oil is optionally replaced by ricinoleic acid.
    Type: Application
    Filed: January 28, 2011
    Publication date: November 22, 2012
    Inventors: Abraham J. Domb, Boris Vaisman, Lior Yankelson, Moran Yaniv
  • Publication number: 20100260703
    Abstract: Methods for soft tissue repair and/or augmentation using injectable, biodegradable polymers are described herein. In one embodiment, the polymer compositions are liquid or pastes at room temperature. In a preferred embodiment, the polymer composition contains liquid or pasty hydroxy fatty acid-based copolyesters, polyester-anhydrides, or combinations thereof. The viscosity of the polymers increases upon contact with bodily fluid to form a solid or semisolid implant suitable for soft tissue repair and/or augmentation. In another embodiment, the polymer composition contains particles of a polymer stereocomplex. One or more active agents may be incorporated into the polymer compositions. Suitable classes of active agents include local anesthetics, anti-inflammatory agents, antibiotics, analgesics, growth factors and agents that induce and/or enhance growth of tissue within the filled cavity or control the growth of a certain type of tissue, and combinations thereof.
    Type: Application
    Filed: October 5, 2008
    Publication date: October 14, 2010
    Inventors: Lior Yankelson, Abraham J. Domb